Maha Hussain
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 0.2%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 182
- Prostate Cancer Diagnosis and Treatment 46
- Oncology 62
- PARP inhibition in cancer therapy 18
- Cancer Treatment and Pharmacology 13
- Co-authors
- Manish Kohli (9 shared papers)Eric Jay Small (11 shared papers)Catherine M. Tangen (34 shared papers)Daniel Peter Petrylak (19 shared papers)E. David Crawford (17 shared papers)Michael Anthony Carducci (26 shared papers)Primo N. Lara (22 shared papers)Mario A. Eisenberger (16 shared papers)
- Journals
- Journal of Clinical Oncology (40 papers)The Journal of Urology (28 papers)Cancer (21 papers)Annals of Oncology (17 papers)European Urology (16 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Maha Hussain
305 papers receiving 31.8k citations
Maha Hussain's Hit Papers
Peers
Comparison fields: 5 of 150
- Pulmonary and Respiratory Medicine 19.0k
- Cancer Research 5.6k
- Oncology 7.8k
- Radiology, Nuclear Medicine and Imaging 3.1k
- Otorhinolaryngology 366
Countries citing papers authored by Maha Hussain
This map shows the geographic impact of Maha Hussain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Hussain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Hussain more than expected).
Fields of papers citing papers by Maha Hussain
This network shows the impact of papers produced by Maha Hussain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Hussain. The network helps show where Maha Hussain may publish in the future.
Co-authors
The 25 scholars most cited alongside Maha Hussain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 314 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer Hit paper breakdown → | 2004 | 3079 |
| 2 | Integrative Clinical Genomics of Advanced Prostate Cancer Hit paper breakdown → | 2015 | 2985 |
| 3 | Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Hit paper breakdown → | 2015 | 2206 |
| 4 | Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group Hit paper breakdown → | 2008 | 1913 |
| 5 | Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer Hit paper breakdown → | 2016 | 1335 |
| 6 | Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 Hit paper breakdown → | 2016 | 1297 |
| 7 | Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group Hit paper breakdown → | 1999 | 880 |
| 8 | Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial Hit paper breakdown → | 2018 | 816 |
| 9 | Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer Hit paper breakdown → | 2018 | 795 |
| 10 | Identification of Targetable FGFR Gene Fusions in Diverse Cancers Hit paper breakdown → | 2013 | 619 |
| 11 | ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Hit paper breakdown → | 2021 | 495 |
| 12 | Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2021 | 488 |
| 13 | Integrative Clinical Genomics of Advanced Prostate Cancer Hit paper breakdown → | 2015 | 461 |
| 14 | Intermittent versus Continuous Androgen Deprivation in Prostate Cancer Hit paper breakdown → | 2013 | 446 |
| 15 | 2006 | 402 | |
| 16 | 2005 | 398 | |
| 17 | Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial Hit paper breakdown → | 2012 | 378 |
| 18 | Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer Hit paper breakdown → | 2016 | 363 |
| 19 | 2007 | 321 | |
| 20 | Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer Hit paper breakdown → | 2020 | 319 |
About Maha Hussain
Maha Hussain is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 314 papers that have together received 32.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (182 papers), Prostate Cancer Diagnosis and Treatment (46 papers), Bladder and Urothelial Cancer Treatments (37 papers), Cancer, Lipids, and Metabolism (29 papers), Radiopharmaceutical Chemistry and Applications (22 papers), PARP inhibition in cancer therapy (18 papers), Hormonal and reproductive studies (14 papers) and Cancer Treatment and Pharmacology (13 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (19.0k citations), Cancer Research (5.6k citations), Oncology (7.8k citations), Radiology, Nuclear Medicine and Imaging (3.1k citations) and Otorhinolaryngology (366 citations). Maha Hussain has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Manish Kohli, Eric Jay Small, Catherine M. Tangen, Daniel Peter Petrylak, E. David Crawford, Michael Anthony Carducci, Primo N. Lara, Mario A. Eisenberger, Robert Dreicer and Derek Raghavan. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Cancer, Annals of Oncology and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.